Pulnovo Medical, a pioneer in breakthrough therapies for treating Pulmonary Hypertension and Heart Failure, today announced the successful completion of an oversubscribed $100 million strategic ...
A recent study published in CHEST found that treatment-naïve adults with obesity-hypoventilation syndrome receiving a ...
Cardiology experts from UCSF Health presented new research and clinical findings at the American College of Cardiology’s (ACC) Annual Scientific Session and Expo in New Orleans, March 28 to 30. The ...
Patients who have heart failure with preserved ejection fraction (HFpEF) and high blood pressure in the lungs (pulmonary ...
Revised 3.2. Measurement of TC, LDL-C, HDL-C, TG, and Non–HDL-C COR 2a: For adults with an LDL-C level <70 mg/dL (<1.8 mmol/L), measurement of direct LDL-C or modified LDL-C estimate is reasonable to ...
Pulmonary hypertension is a condition where specialist input is essential, yet the day-to-day management of many patients takes place in local hospitals, usually in general respiratory clinics, far ...
Pulmonary hypertension (PH) is a progressive disease marked by pulmonary arterial remodeling and right ventricular dysfunction. The molecular mechanisms driving this remodeling, particularly ECM ...
A decade later, I still remember standing in the kitchen on a phone call that would change my life. On that morning in March 2016, I left my apartment and returned nearly two weeks later with a ...
AURA Phase 2 clinical trial designed to evaluate the safety and efficacy of AP02 compared to placebo in patients with idiopathic pulmonary fibrosis (IPF) BOSTON, March 23, 2026 (GLOBE NEWSWIRE)-- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results